Facebook Facebook Share

Target Ovarian Cancer’s UK-wide ovarian cancer research programme is now closed for applications.  Please check this page and our news stories for announcements of further funding.

Target Ovarian Cancer research awards

Innovation in ovarian cancer research award

To accelerate research that delivers patient benefit. These awards are not designed for basic or early discovery studies.

What we’re looking for
Translational studies linked to approved clinical trials:

  • Novel tumour classification to aid the development of personalised medicine.
  • Understanding the development of drug resistance.
  • Identification of novel biomarkers (predictive, diagnostic or prognostic) and potential new therapeutic targets.

Preclinical development of new therapeutic targets:

  • Target validation/proof of concept studies.
  • Early stage development of novel therapeutic agents with view to generating a realisable asset to attract commercial interest / further funding upon grant end.


Supportive and palliative care award


To improve the quality of life for women living with ovarian cancer

What we’re looking for
Projects aimed at the prevention and management of the adverse effects of ovarian cancer and its treatment. This includes management of physical and psychological symptoms and side effects across the continuum of the cancer. Proposals including other pelvic cancers, in addition to ovarian cancer, will also be considered.


What next?

Target Ovarian Cancer does not receive any state funding. This research is only made possible through donations and legacies. If you would like to contribute to these research projects and improve the lives of women with ovarian cancer, please visit our donate page.